Clinical Trials List
Protocol NumberCLS2702-ESO-TW02
NCT Number(ClinicalTrials.gov Identfier)-
Not yet recruiting
2020-08-01 - 2023-12-31
Phase III
Terminated2
ICD-10C15.3
Malignant neoplasm of upper third of esophagus
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.3
Malignant neoplasm of upper third of esophagus
-
-
Sponsor
-
-
Trial scale
Taiwan Multiple Center
-
Update
2026/09/24
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
JANG-MING LEE
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
0 participants
